Radiation Oncology

Latest News

Retrospective analysis at SNMMI 2025 revealed α-FRT with 225AC-3BP-3940 was well tolerated and elicited responses in pretreated metastatic breast cancer.
225AC-3BP-3940 Is Safe, Shows Activity in Heavily Pretreated Advanced Breast Cancer

June 24th 2025

Retrospective analysis at SNMMI 2025 revealed α-FRT with 225AC-3BP-3940 was well tolerated and elicited responses in pretreated metastatic breast cancer.

Use of PET-guided radiotherapy may enable the opportunity to incorporate biological information into the planning and delivery of radiation.
PET-Guided Radiotherapy Successfully Manages Lung and Bone Tumors

June 23rd 2025

The use of 68Ga-Pentixafor compliments fluorodeoxyglucose and had no correlation with CXCR4 immunohistochemistry.
CXCR4 Expression in Gynecologic Malignancies Correlates With OS

June 23rd 2025

A retrospective study shows that [177Lu]Lu-PSMA-617 retreatment led to a median OS of 14.5 months in castration-resistant prostate cancer.
Radioligand Therapy Retreatment Shows Promise in Metastatic CRPC

June 23rd 2025

Twice-Daily Hyperfractionated Thoracic Radiotherapy Effective at 60 Gy in SCLC
Twice-Daily Hyperfractionated Thoracic Radiotherapy Effective at 60 Gy in SCLC

June 6th 2025